Clioquinol
Active ingredient · 5 therapeutic classes
Sold as LOCACORTEN VIOFORM · VIOFORM HYDROCORTISONE · LOCACORTEN VIOFORM…
- Drug class
- Quinoline Derivatives
- Availability
- See label
- Routes
- Otic, Topical
- Markets covered
- 2
- Products on record
- 11
Overview
Clioquinol is an active pharmaceutical ingredient in the Quinoline Derivatives group (G01AC). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 7 | April 10, 2026 |
| CA Canada | Health Canada | 4 | December 29, 2025 |
GBUnited Kingdom· MHRA
7 products
Uses
Inflammatory conditions of the external ear where a secondary infection is suspected. Otorrhoea.
How to take
CACanada· Health Canada
4 products
Uses
LOCACORTEN VIOFORM EARDROPS (flumethasone pivalate and clioquinol drops) is indicated for: • otitis externa • otomycosis including that due to Aspergillus niger To reduce the development of drug-resistant bacteria and maintain the effectiveness of LOCACORTEN VIOFORM EARDROPS and other antibacterial drugs, LOCACORTEN VIOFORM EARDROPS should be used only to reduce the risk of infections that are proven or strongly suspected to be caused by susceptible bacteria.
1 Pediatrics Pediatrics (< 2 years of age): Health Canada has not authorized an indication in children under 2 years of age. 2 Geriatrics Geriatrics (>65 years of age): LOCACORTEN VIOFORM EARDROPS should be used with caution in geriatric patients, taking into consideration the greater frequency of decreased hepatic or renal function, of cardiovascular disease, and of concomitant disease or other drug therapy in this patient population.
Drug interactions
Known interactions involving Clioquinol. Select one for details. This list is informational and not a complete interaction checker.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]MHRA (UK) · PL200720012 · revised April 10, 2026
- [2]Health Canada (DPD) · 00074454 · revised December 29, 2025
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.